Report cover image

India Oligonucleotides Synthesis Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Aug 01, 2023
Length 86 Pages
SKU # DAABD18185793

Description

India Oligonucleotides Synthesis Market - Industry Trends and Forecast to 2030


India Oligonucleotides Synthesis Market is expected to reach USD 191.35 Million by 2030 from USD 108.91 Million in 2022, growing at a CAGR of 7.4% during the forecast period of 2023 to 2030.
Market Segmentation:
India Oligonucleotides Synthesis Market, By Type (Custom Oligos, Predesigned Oligos), By Product Type (Equipment's, Reagents, Consumables & Accessories), Synthesis Method (Solid Phase Oligo Synthesis Method and Liquid/Enzymatic Phase Oligo Synthesis Method), Application (Diagnostics, Therapeutics, Research, Agriculture, Food, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organization, Research & Academic Institutes, Forensic Labs), Distribution Channel (Direct Tender, Retail Sales and Others), Country (India)
-Industry Trends and Forecast to 2030
Overview of India Oligonucleotides Synthesis Market Dynamics

Driver

• Rising use of oligonucleotide synthesis in various applications

Restrain

• Competition from other emerging market players

Opportunity

• Increased focus on government initiatives and R&D

Market Players:

Some of the key players operating in the India Oligonucleotides Synthesis market are:
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• DH Life Sciences, LLC.
• LGC Limited
• Eurofins Genomics
• GE HealthCare
• METTLER TOLEDO
• TriLink BioTechnologies
• Ajinomoto Bio-Pharma.

Table of Contents

86 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The India Oligonucleotides Synthesis Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market End User Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Pricing Strategy
4.4 India Oligonucleotides Synthesis Market, Conjoint Analysis
4.4.1 Feature- Customization
4.4.2 Feature- Additional Services
5 Regulatory Compliance
5.1 Regulatory Authorities:
5.2 Regulatory Scenario In India -
6 Market Overview
6.1 Drivers
6.1.1 Use Of Synthesized Oligonucleotides In Various Applications
6.1.2 Increasing Government Investments And R&D Expenditure
6.2 Restraints
6.2.1 Rising Competition Among Market Players
6.2.2 Lack Of Trained Professionals
6.3 Opportunity
6.3.1 Rising Technological Advancements
6.4 Challenge
6.4.1 Limitation Of Oligonucleotides Synthesis
7 India Oligonucleotides Synthesis Market, By Type
7.1 Overview
7.2 Custom Oligos
7.3 Predesigned Oligos
8 India Oligonucleotides Synthesis Market, By Product Type
8.1 Overview
8.2 Equipment's
8.2.1 Oligosynthesizer
8.2.1.1 Small Scale Synthesis
8.2.1.2 Medium Scale Synthesis
8.2.1.3 Large Scale Synthesis
8.2.2 Computer-controlled Instruments
8.2.2.1 Column Format
8.2.2.2 Multi-well Plate Format
8.3 Reagents, Consumables & Accessories
8.3.1 Capping Reagents
8.3.2 Activator Solution
8.3.2.1 Activator Solution (Dci)
8.3.2.2 Activator Solution (Ett)
8.3.2.3 Activator Solution (Btt)
8.3.2.4 Others
8.3.3 Oxidizer
8.3.4 Deblock Solution
8.3.4.1 Deblock Dcm Solution
8.3.4.2 Deblock Dce Solution 49 
8.3.5 Coupling
8.3.5.1 Anhydrous Acetonitrile
8.3.5.2 Activators
8.3.6 Deprotected Reagents
8.3.7 Others
9 India Oligonucleotides Synthesis Market, By Synthesis Method
9.1 Overview
9.2 Solid Phase Oligo Synthesis Method
9.2.1 Column-based Oligonucleotide Synthesis
9.2.2 Microarray-based Oligonucleotide Synthesis
9.3 Liquid/Enzymatic Phase Oligo Synthesis Method
9.3.1 Template Independent Polymerase-based Method
9.3.2 Template-dependent Polymerase Mediated Oligo Synthesis
10 India Oligonucleotides Synthesis Market, By Application
10.1 Overview
10.2 Diagnostics
10.2.1 Infectious Diseases
10.2.2 Cancer
10.2.3 Neurological Disease
10.2.4 Cardiovascular Disease
10.2.5 Others
10.3 Therapeutics
10.3.1 Rnai Oligonucleotide-based Therapies
10.3.2 Dna/Antisense Oligonucleotide-based Therapies
10.3.3 Immunotherapy (Cpg Oligonucleotide-based Therapies)
10.3.4 Nucleic Acid Aptamers
10.4 Research
10.4.1 Aptamer Design
10.4.2 Allele-specific Testing
10.4.3 Triplex-forming Oligonucleotides
10.4.4 Other Research Applications
10.5 Agriculture
10.6 Food
10.7 Others 60 
11 India Oligonucleotides Synthesis Market, By End User
11.1 Overview
11.2 Pharmaceutical & Biotechnology Companies
11.3 Diagnostic Centers
11.4 Contract Research Organization
11.5 Research & Academic Institutes
11.6 Forensic Labs
12 India Oligonucleotides Synthesis Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.3 Retail Sales
12.4 Others
13 India Oligonucleotides Synthesis Market, Company Landscape
13.1 Company Share Analysis: India
14 Company Profile
14.1 Thermo Fisher Scientific
14.1.1 Company Snapshot
14.1.2 Revenue Analysis
14.1.3 Product Portfolio
14.1.4 Recent Developments
14.2 Agilent Technologies Inc
14.2.1 Company Snapshot
14.2.2 Revenue Analysis
14.2.3 Product Portfolio
14.2.4 Recent Developments
14.3 Merck Kgaa
14.3.1 Company Snapshot
14.3.2 Revenue Analysis
14.3.3 Product Portfolio
14.3.4 Recent Development
14.4 Danaher
14.4.1 Company Snapshot
14.4.2 Revenue Analysis
14.4.3 Product Portfolio
14.4.4 Recent Development 75 
14.5 Lgc Limited
14.5.1 Company Snapshot
14.5.2 Product Portfolio
14.5.3 Recent Development
14.6 Ajinomoto Bio-pharma
14.6.1 Company Snapshot
14.6.2 Product Portfolio
14.6.3 Recent Development
14.7 Eurofins Genomics
14.7.1 Company Snapshot
14.7.2 Product Portfolio
14.7.3 Recent Development
14.8 General Electric
14.8.1 Company Snapshot
14.8.2 Revenue Analysis
14.8.3 Product Portfolio
14.8.4 Recent Development
14.9 Mettler Toledo India Private Ltd
14.9.1 Company Snapshot
14.9.2 Product Portfolio
14.9.3 Recent Development
14.10 Trilink Biotechnologies, Llc
14.10.1 Company Snapshot
14.10.2 Product Portfolio
14.10.3 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables
Table 1 The Average Cost Of Oligonucleotides Synthesis In India:
Table 2 India Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 3 India Oligonucleotides Synthesis Market, By Product Type, 2021-2030 (Usd Million)
Table 4 India Equipment's In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 5 India Oligosynthesizer In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 6 India Computer-controlled Instruments In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 7 India Reagents, Consumables & Accessories In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 8 India Activator Solution In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 9 India Deblock Solution In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 10 India Coupling In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 11 India Oligonucleotides Synthesis Market, By Synthesis Method, 2021-2030 (Usd Million)
Table 12 India Solid Phase Oligo Synthesis Method In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 13 India Liquid/Enzymatic Phase Oligo Synthesis Method In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 14 India Oligonucleotides Synthesis Market, By Application, 2021-2030 (Usd Million)
Table 15 India Diagnostics In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 16 India Therapeutics In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 17 India Research In Oligonucleotides Synthesis Market, By Type, 2021-2030 (Usd Million)
Table 18 India Oligonucleotides Synthesis Market, By End User, 2021-2030 (Usd Million)
Table 19 India Oligonucleotides Synthesis Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures
Figure 1 India Oligonucleotides Synthesis Market: Segmentation
Figure 2 India Oligonucleotides Synthesis Market: Data Triangulation
Figure 3 India Oligonucleotides Synthesis Market: Droc Analysis
Figure 4 India Oligonucleotides Synthesis Market: Global Vs Regional Market Analysis
Figure 5 India Oligonucleotides Synthesis Market: Company Research Analysis
Figure 6 India Oligonucleotides Synthesis Market: Interview Demographics
Figure 7 India Oligonucleotides Synthesis Market: Dbmr Market Position Grid
Figure 8 India Oligonucleotides Synthesis Market: Market End User Coverage Grid
Figure 9 India Oligonucleotides Synthesis Market: Vendor Share Analysis
Figure 10 India Oligonucleotides Synthesis Market: Segmentation
Figure 11 Increasing Application Of Oligonucleotides Synthesis Is Expected To Drive The Growth Of The India Oligonucleotides Synthesis Market In The Forecast Period
Figure 12 The Custom Oligos Segment Is Expected To Account For The Largest Share Of The India Oligonucleotides Synthesis Market In 2023 And 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The India Oligonucleotides Synthesis Market
Figure 14 India Oligonucleotides Synthesis Market: By Type, 2022
Figure 15 India Oligonucleotides Synthesis Market: By Product Type, 2022
Figure 16 India Oligonucleotides Synthesis Market: By Synthesis Method, 2022
Figure 17 India Oligonucleotides Synthesis Market: By Application, 2022
Figure 18 India Oligonucleotides Synthesis Market: By End User, 2022
Figure 19 India Oligonucleotides Synthesis Market: By Distribution Channel, 2022
Figure 20 India Oligonucleotides Synthesis Market: Company Share 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us